364 related articles for article (PubMed ID: 22248965)
1. Neuroblastoma.
Davidoff AM
Semin Pediatr Surg; 2012 Feb; 21(1):2-14. PubMed ID: 22248965
[TBL] [Abstract][Full Text] [Related]
2. Long-term prognosis of low-risk neuroblastoma treated by surgery alone: an experience from a single institution of China.
Yao W; Li K; Dong KR; Zheng S; Xiao XM
World J Pediatr; 2019 Apr; 15(2):148-152. PubMed ID: 30446974
[TBL] [Abstract][Full Text] [Related]
3. Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.
Owens C; Irwin M
Crit Rev Clin Lab Sci; 2012; 49(3):85-115. PubMed ID: 22646747
[TBL] [Abstract][Full Text] [Related]
4. Current aspects of biology, risk assessment, and treatment of neuroblastoma.
Haase GM; Perez C; Atkinson JB
Semin Surg Oncol; 1999 Mar; 16(2):91-104. PubMed ID: 9988866
[TBL] [Abstract][Full Text] [Related]
5. Neuroblastoma: biology, prognosis, and treatment.
Park JR; Eggert A; Caron H
Pediatr Clin North Am; 2008 Feb; 55(1):97-120, x. PubMed ID: 18242317
[TBL] [Abstract][Full Text] [Related]
6. Recent biologic and genetic advances in neuroblastoma: Implications for diagnostic, risk stratification, and treatment strategies.
Newman EA; Nuchtern JG
Semin Pediatr Surg; 2016 Oct; 25(5):257-264. PubMed ID: 27955728
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of abdominal neuroblastoma in Essen].
Lange R; Kremens B; Grigoleit U; Erhard J
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():1073-7. PubMed ID: 9101784
[TBL] [Abstract][Full Text] [Related]
8. Image-defined Risk Factors Correlate with Surgical Radicality and Local Recurrence in Patients with Neuroblastoma.
Pohl A; Erichsen M; Stehr M; Hubertus J; Bergmann F; Kammer B; von Schweinitz D
Klin Padiatr; 2016 Apr; 228(3):118-23. PubMed ID: 26930233
[TBL] [Abstract][Full Text] [Related]
9. Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors.
Ahmed AA; Zhang L; Reddivalla N; Hetherington M
Pediatr Hematol Oncol; 2017 Apr; 34(3):165-185. PubMed ID: 28662353
[TBL] [Abstract][Full Text] [Related]
10. Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.
Padovan-Merhar OM; Raman P; Ostrovnaya I; Kalletla K; Rubnitz KR; Sanford EM; Ali SM; Miller VA; Mossé YP; Granger MP; Weiss B; Maris JM; Modak S
PLoS Genet; 2016 Dec; 12(12):e1006501. PubMed ID: 27997549
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of relapsed abdominal high-risk neuroblastoma.
Dübbers M; Simon T; Berthold F; Fischer J; Volland R; Hero B; Cernaianu G
J Pediatr Surg; 2018 Mar; 53(3):558-566. PubMed ID: 29021103
[TBL] [Abstract][Full Text] [Related]
12. [Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].
Pérel Y; Valteau-Couanet D; Michon J; Lavrand F; Coze C; Bergeron C; Notz A; Plantaz D; Chastagner P; Bernard F; Thomas C; Rubie H
Arch Pediatr; 2004 Jul; 11(7):834-42. PubMed ID: 15234382
[TBL] [Abstract][Full Text] [Related]
13. Delayed surgery and bone marrow transplantation for widespread neuroblastoma.
Moss TJ; Fonkalsrud EW; Feig SA; Lenarsky C; Selch M; Wells J; Seeger RC
Ann Surg; 1987 Oct; 206(4):514-20. PubMed ID: 3310932
[TBL] [Abstract][Full Text] [Related]
14. Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials.
London WB; Bagatell R; Weigel BJ; Fox E; Guo D; Van Ryn C; Naranjo A; Park JR
Cancer; 2017 Dec; 123(24):4914-4923. PubMed ID: 28885700
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of intensive surgery with intraoperative radiation for advanced neuroblastoma: does it really make sense?
Kuroda T; Saeki M; Honna T; Masaki H; Tsunematsu Y
J Pediatr Surg; 2003 Dec; 38(12):1735-8. PubMed ID: 14666455
[TBL] [Abstract][Full Text] [Related]
16. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of segmental alterations determines progression in neuroblastoma.
Schleiermacher G; Janoueix-Lerosey I; Ribeiro A; Klijanienko J; Couturier J; Pierron G; Mosseri V; Valent A; Auger N; Plantaz D; Rubie H; Valteau-Couanet D; Bourdeaut F; Combaret V; Bergeron C; Michon J; Delattre O
J Clin Oncol; 2010 Jul; 28(19):3122-30. PubMed ID: 20516441
[TBL] [Abstract][Full Text] [Related]
18. The role of multimodal therapy in patients with local and regional neuroblastoma.
Evans AE; D'Angio GJ; Koop CE
J Pediatr Surg; 1984 Feb; 19(1):77-80. PubMed ID: 6366182
[TBL] [Abstract][Full Text] [Related]
19. Advances in the diagnosis and treatment of neuroblastoma.
Weinstein JL; Katzenstein HM; Cohn SL
Oncologist; 2003; 8(3):278-92. PubMed ID: 12773750
[TBL] [Abstract][Full Text] [Related]
20. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
Yalçin B; Kremer LC; Caron HN; van Dalen EC
Cochrane Database Syst Rev; 2013 Aug; (8):CD006301. PubMed ID: 23970444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
